Sofosbuvir-Velpatasvir Clinical Trials

1 actively recruiting trial

Also known as: (SOF/VEL)

Pipeline

Phase 3: 1

Top Sponsors

Atea Pharmaceuticals, Inc.1

Indications

HEPATITIS C VIRUS CHRONIC INFECTION1
Liver Disease1
Hepatitis C, Chronic1
Hepatitis C1
Hepatitis C Virus Infection1

Other1 trial

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.